Attending this event?
Back To Schedule
Monday, September 19 • 9:45am - 10:30am
Panel: Battling Biotech’s Bear Market

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

There’s no doubt that biotech is facing tough times: shares are in freefall, investors have shut off the tap that flowed in the wake of the COVID crisis, clinical results are beginning to thin the good ideas from the bad and small companies are being forced to lay off staff. How can companies stay afloat, raise money and keep alive in this bear market?

avatar for Querida Anderson

Querida Anderson

Managing Editor, Fierce Biotech
Querida Anderson is the managing editor for Fierce Biotech, Healthcare, Medtech and Pharma. Before joining Fierce in June 2021, she was the editor in chief of GlobalData’s investigative pharma news team, formerly known as BioPharm Insight when it was owned by the Financial Times... Read More →

avatar for Stefan Vitorovic, M.S., M.B.A.

Stefan Vitorovic, M.S., M.B.A.

Co-Founder and Managing Director,, Vida Ventures
Stefan Vitorovic is Co-Founder and Managing Director at Vida Ventures.Prior to co-founding Vida Ventures, Stefan was an investment professional at Third Rock Ventures, an early-stage life sciences venture capital firm. At Third Rock, he was part of the founding team of Decibel Therapeutics... Read More →
avatar for Maha Katabi, CFA

Maha Katabi, CFA

General Partner, Sofinnova Investments
Maha Katabi is an experienced investor with over two decades in managing public and private biotech companies through bull and bear markets. She is focused on investing in development stage biopharmaceuticals and is currently a member of the board of directors of Aerovate (AVTE... Read More →
avatar for Adam Friedman, M.D., Ph.D.

Adam Friedman, M.D., Ph.D.

President, Corporate Strategy & Business Development, Scorpion Therapeutics
Dr. Friedman has been Scorpion Therapeutics’ President, Corporate Strategy & Business Development since September 2021, after serving as interim Chief Executive Officer between February 2021 and August 2021, as Executive Vice President, Corporate Development & Operations from July... Read More →
avatar for Marian Nakada, Ph.D.

Marian Nakada, Ph.D.

Vice President, Venture Investments, JJDC
Marian Nakada, VP Venture Investments for Johnson & Johnson Innovation – JJDC, has over 30 years of experience in the pharmaceutical industry, starting her career at the laboratory bench at Centocor and moving to a research leadership role before Centocor’s acquisition by Johnson... Read More →

Monday September 19, 2022 9:45am - 10:30am EDT